Anjan Bera
Post Graduate Institute of Medical Education and Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anjan Bera.
IEEE Transactions on Plasma Science | 2010
Udaybir Singh; Anjan Bera; Narendra Kumar; L. P. Purohit; A. K. Sinha
This paper presents a three-dimensional (3-D) simulation of a triode-type magnetron injection gun (MIG) for a 42-GHz 200-kW gyrotron with a transverse-to-axial velocity ratio of the electron beam at 1.22 and a maximum transverse-velocity spread of 3.2%. The operating mode of the gyrotron is TE_03, and it is operated in the fundamental harmonic. The MIG has been designed by using some tradeoff equations and the 3-D particle-tracing code (computer simulation technology). The simulated results have been validated with the results obtained using the 3-D code OPERA Vector Fields and the two-dimensional trajectory codes EGUN and TRAK.
Journal of Thyroid Research | 2013
Ritesh Kumar; Divya Khosla; Narendra Kumar; Sushmita Ghoshal; Anjan Bera; Ashim Das; Suresh C. Sharma
Primary thyroid lymphoma (PTL) is a rare malignancy and represents 2%–5% of all thyroid malignancies and 1%–2.5% of all malignant lymphomas. We present our institutes experience in combined modality management of 16 successive patients of PTL treated from 2005 to 2010. The median age of the patients was 56.0 years. Five patients were males, and 11 patients were females. An enlarging thyroid mass was the most common presenting symptom. 14 patients had diffuse large B-cell lymphoma, and 2 patients had follicular lymphoma. The most common stage of presentation was stage II comprising 6 (37.5%) patients. All patients received CCT, and only 12 patients received involved field RT with a median dose of 36.0 Gy. 10 patients (62.5%) had CR, and 6 patients (27.5%) had PR. Eight patients had disease progression in subsequent followup and this included the initial 6 patients with PR. The 5-year DFS was 40.0%, and median DFS was 47 months. The 5-year OS was 41.0%, and median OS was 51 months. Most common presentation in our series was locally advanced tumors. Most of these patients require combined modality management. Risk-adapted and multimodality approach is the need of the hour to achieve good control rates while minimizing treatment related toxicity.
Journal of Neurosciences in Rural Practice | 2013
Narendra Kumar; Pankaj Kumar; Shabab Lalit Angurana; Divya Khosla; Kanchan Kumar Mukherjee; Rupali Aggarwal; Ritesh Kumar; Anjan Bera; Suresh C. Sharma
Aims: We present retrospective analysis of patients of glioblastoma multiforme (GBM) and discuss clinical characteristics, various treatment protocols, survival outcomes, and prognostic factors influencing survival. Materials and Methods: From January 2002 to June 2009, 439 patients of GBM were registered in our department. The median age of patients was 50 years, 66.1% were males, and 75% underwent complete or near-total excision. We evaluated those 360 patients who received radiotherapy (RT). Radiotherapy schedule was selected depending upon pre-RT Karnofsky Performance Status (KPS). Patients with KPS < 70 (Group I, n = 48) were planned for RT dose of 30-35 Gy in 10-15 fractions, and patients with KPS ≥ 70 (Group II, n = 312) were planned for 60 Gy in 30 fractions. In group I, six patients and in group II, 89 patients received some form of chemotherapy (lomustine or temozolomide). Statistical Analysis Used: Statistical analysis was done using Statistical Package for Social Sciences, version 12.0. Overall survival (OS) was calculated using Kaplan-Meier method, and prognostic factors were determined by log rank test. The Cox proportional hazards model was used for multivariate analysis. Results: The median follow-up was 7.53 months. The median and 2-year survival rates were 6.33 months and 2.24% for group I and 7.97 months and 8.21% for group II patients, respectively (P = 0.001). In multivariate analysis, site of tumor (central vs. others; P = 0.006), location of tumor (parietal lobe vs. others; P = 0.003), RT dose (<60 Gy vs. 60 Gy; P = 0.0001), and use of some form of chemotherapy (P = 0.0001) were independent prognostic factors for survival. Conclusions: In patients with GBM, OS and prognosis remains dismal. Whenever possible, we should use concurrent and/or adjuvant chemotherapy to maximize the benefits of post-operative radiotherapy. Patients with poor performance status may be considered for hypofractionated RT schedules, which have similar median survival rates as conventional RT.
Indian Journal of Dermatology | 2011
Narendra Kumar; Anjan Bera; Ritesh Kumar; Sushmita Ghoshal; Shabab Lalit Angurana; Radhika Srinivasan
Subcutaneous metastasis from carcinoma larynx is a rare presentation and to the phalynx is the rarest. We herein describe a case report of carcinoma supraglottic larynx, which is involving all five distal phalanges of left hand with simultaneous metastases to lung and liver. Acrometastasis is an unusual presentation, which might mimic an infectious or inflammatory pathology. The brief report highlights the importance of clinical awareness of metastatic dissemination to unusual sites in the face of increasing cancer survivorship.
Asia-pacific Journal of Clinical Oncology | 2013
Rakesh Kapoor; Divya Khosla; Pankaj Kumar; Narendra Kumar; Anjan Bera
Aim: Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. There is limited published data on GIST from the Indian subcontinent. This 5‐year retrospective analysis of 49 patients treated for GIST reports clinical and pathological features and survival outcome by risk stratification.
Physical Review B | 2016
Kaustuv Manna; R. Sarkar; S. Fuchs; Y. A. Onykiienko; Anjan Bera; G. Aslan Cansever; S. Kamusella; Andrey Maljuk; C. G. F. Blum; L. T. Corredor; A. U. B. Wolter; S. M. Yusuf; M. Frontzek; L. Keller; M. Iakovleva; E. Vavilova; H.-J. Grafe; V. Kataev; H.-H. Klauss; D. S. Inosov; S. Wurmehl; B. Buechner
We report the structural, magnetic, and thermodynamic properties of the double perovskite compound
Indian Journal of Palliative Care | 2011
Narendra Kumar; Ritesh Kumar; Anjan Bera; Pankaj Kumar; Shabab Lalit Angurana; Sushmita Ghosal; Radhika Srinivasan; Suresh C. Sharma
{\mathrm{La}}_{2}{\mathrm{CuIrO}}_{6}
Journal of Cancer Research and Therapeutics | 2013
Narendra Kumar; Ritesh Kumar; Anjan Bera; Sushmita Ghoshal; Rakesh Kapoor; Bd Radotra; Suresh C. Sharma
from x-ray, neutron diffraction, neutron depolarization,
Journal of Applied Physics | 2013
Chanchal Sow; D. Samal; P. S. Anil Kumar; Anjan Bera; S. M. Yusuf
\mathit{dc}
Indian Journal of Surgical Oncology | 2012
Rakesh Kapoor; Anjan Bera; Uma Nahar Saikia; Ritesh Kumar; Divya Khosla; Narender Kumar
magnetization,
Collaboration
Dive into the Anjan Bera's collaboration.
Post Graduate Institute of Medical Education and Research
View shared research outputsPost Graduate Institute of Medical Education and Research
View shared research outputsPost Graduate Institute of Medical Education and Research
View shared research outputs